Showing results (141-150 of 150) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1990
Sequential histomorphometric changes in cancellous bone from ovariohysterectomized dogsR W Boyce, A F Franks, M L Jankowsky, et al.Journal of Diabetes Research|September 21, 2017
Liver Biomarkers and Lipid Profiles in Mexican and Mexican-American 10- to 14-Year-Old Adolescents at Risk for Type 2 DiabetesAna Cecilia Fernández-Gaxiola, Roxana Valdés-Ramos, Kimberly G Fulda, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 20, 2016
Correlation of Lipid Profile and Risk of Developing Type 2 Diabetes Mellitus in 10-14 Year Old ChildrenNusrath M Habiba, Kimberly G Fulda, Riyaz Basha, et al.Bone|May 1, 1993
Calcium-restricted ovariectomized Sinclair S-1 minipigs: an animal model of osteopenia and trabecular plate perforationL Mosekilde, S E Weisbrode, J A Safron, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 1993
Evaluation of the skeletal effects of combined mild dietary calcium restriction and ovariectomy in Sinclair S-1 minipigs: a pilot studyL Mosekilde, S E Weisbrode, J A Safron, et al.Bioorganic & Medicinal Chemistry Letters|April 8, 2006
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug designDaniel J Parks, Louis V LaFrance, Raul R Calvo, et al.American Journal of Human Genetics|October 22, 2013
Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiencyKarin Chen, Emily M Coonrod, Attila Kumánovics, et al.Molecular Cancer Therapeutics|January 25, 2006
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivoHolly K Koblish, Shuyuan Zhao, Carol F Franks, et al.Molecular Cancer Therapeutics|November 6, 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemiaCarl L Manthey, Dana L Johnson, Carl R Illig, et al.Journal of Medicinal Chemistry|February 18, 2005
Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cellsBruce L Grasberger, Tianbao Lu, Carsten Schubert, et al.Pageof 15